BlackRock Institutional Trust’s Altimmune ALT Stock Holding History

BlackRock Institutional Trust’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.58M	Sell	1,618 -6	-0.4%	-$5.38K	﹤0.01%	3142
2016 Q3	$1.41M	Sell	1,624 -9	-0.6%	-$7.06K	﹤0.01%	3176
2016 Q2	$1.2M	Buy	1,633 +1,567	+2,374%	+$1.07M	﹤0.01%	3244
2016 Q1	$38K	Hold	66	–	–	﹤0.01%	3808
2015 Q4	$38K	Hold	66	–	–	﹤0.01%	3832
2015 Q3	$26K	Buy	66 +44	+200%	+$20.8K	﹤0.01%	3871
2015 Q2	$12K	Buy	+22	New	+$11.1K	﹤0.01%	3866
2014 Q3	–	Sell	-86	Closed	-$37K	–	3833
2014 Q2	$37K	Sell	86 -218	-72%	-$98.6K	﹤0.01%	3843
2014 Q1	$167K	Sell	304 -7	-2%	-$4.09K	﹤0.01%	3723
2013 Q4	$174K	Buy	311 +65	+26%	+$38.8K	﹤0.01%	3738
2013 Q3	$155K	Sell	246 -44	-15%	-$25.2K	﹤0.01%	3714
2013 Q2	$138K	Buy	+290	New	+$144K	﹤0.01%	3695

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Institutional Trust's ALT Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Altimmune (ALT) stake by 0.37% in Q4 2016, selling an estimated $5.38K and leaving 1,618 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

BlackRock Institutional Trust first reported a position in ALT in Q2 2013 and has held it in 12 quarters since. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2016.

BlackRock Institutional Trust held 1,618 shares of Altimmune worth $1.58M as of Q4 2016.
BlackRock Institutional Trust sold 6 Altimmune shares in Q4 2016, an estimated $5.38K.
Altimmune made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3142 holding.
BlackRock Institutional Trust first reported a position in Altimmune in Q2 2013 and has held it in 12 quarters since.
88 funds tracked by Wall St. Rank held Altimmune as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.